3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one

This compound is an experimental small molecule belonging to the class of organic compounds known as **benzothiadiazine dioxides**. It features a quinoline core substituted with a benzothiadiazine dioxide moiety and an isopentyl group. There is no publicly available information regarding its mechanism of action or clinical indications. The compound has been cataloged in drug databases as experimental and does not have any reported therapeutic use or development status beyond basic research[1][2].

Other names

3-(1,1-dioxido-4H-benzo[e][1,2,4]thiadiazin-3-yl)-4-hydroxy-1-isopentylquinolin-2(1H)-one3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydroquinolin-3-yl]-4H-benzo[e][1,2,4]thiadiazine 7-oxo derivative (not standard but sometimes referenced in literature)DB07275 (DrugBank accession number)